SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

22 Jul 2025 Evaluate
The total revenue hovered 117.78% to Rs. 3547.58 millions for the June 2025 quarter as against Rs. 1628.99 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 141.34% to Rs. 911.70  millions  from Rs. 377.77 millions in previous same quarter.OP of the company witnessed a marginal growth to 1292.48 millions from 529.78 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 3547.58 1628.99 117.78 3547.58 1628.99 117.78 10299.85 7115.98 44.74
Other Income 82.54 87.15 -5.29 82.54 87.15 -5.29 462.56 288.60 60.28
PBIDT 1292.48 529.78 143.97 1292.48 529.78 143.97 4239.86 2580.90 64.28
Interest 6.90 0.27 2455.56 6.90 0.27 2455.56 0.98 1.61 -39.13
PBDT 1285.58 529.51 142.79 1285.58 529.51 142.79 4238.88 2481.86 70.79
Depreciation 56.98 34.82 63.64 56.98 34.82 63.64 177.89 280.91 -36.67
PBT 1228.60 494.69 148.36 1228.60 494.69 148.36 4060.99 2200.95 84.51
TAX 316.90 116.92 171.04 316.90 116.92 171.04 1008.96 563.44 79.07
Deferred Tax 18.90 19.42 -2.68 18.90 19.42 -2.68 41.21 21.44 92.21
PAT 911.70 377.77 141.34 911.70 377.77 141.34 3052.03 1637.51 86.38
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 36.43 32.52 12.02 36.43 32.52 12.02 41.16 36.27 13.50

Blue Jet Healthcare Share Price

407.30 37.00 (9.99%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×